Lancashire and South Cumbria
Formulary
Formulary
1 Gastro-intestinal system
01-06-07 Other drugs used in constipation
| Linaclotide Constella® |
|
Formulary
|
Capsules 290 micrograms Prescribe in line with CG61. If no improvement in symptoms at follow up then discontinue |
 NICE CG61: Irritable bowel syndrome in adults: diagnosis and management |
|
Green restricted in West Lancashire only| Prucalopride Resolor® |
|
Formulary
|
Tablets f/c 1mg, 2mg LSCMMG recommends the use of prucalopride for the symptomatic treatment of chronic constipation in both women and men, as per the product licensing. Prescribing should be as per the recommendations in TA211. |
|
NICE TA211: Prucalopride for the treatment of chronic constipation in women |
|
|
Links
Lancashire and South Cumbria Infant Feeding Network: Diagnosis and Management of Milk Allergy and Intolerance Guideline- LSCMMG: Biosimilars policy position statement
- LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway
- LSCMMG: Primary Care Constipation Guidelines
- NICE CG184: Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
- NICE NG147: Diverticular disease: diagnosis and management
- NICE TA211: Prucalopride for the treatment of chronic constipation in women
- NICE TA318: Lubiprostone for treating chronic idiopathic constipation